Zack Lynch

Insider Reports History

Entity
Individual
Location
C/O Pear Therapeutics, Inc., 200 State Street, 13 Th Floor, Boston, MA
Signature
/s/ Stacie S. Aarestad, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Zack Lynch:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Pear Therapeutics, Inc. Director Class A Common Stock 9.68M Dec 3, 2021 by JAZZ Human Performance Technology Fund, L.P.
Pear Therapeutics, Inc. Director Class A Common Stock 1.08M Dec 3, 2021 by JAZZ Human Performance Opportunity Fund, L.P.
Pear Therapeutics, Inc. Director Stock Option (Right to Buy) 29.4K Dec 3, 2021 Direct

Insider Reports Filed by Zack Lynch

Symbol Company Period Transactions Value $ Form Type Date Filed Role
PEARQ Pear Therapeutics, Inc. Dec 3, 2021 4 $100K 4 Dec 7, 2021 Director
PEARQ Pear Therapeutics, Inc. Dec 3, 2021 0 $0 3 Dec 7, 2021 Director